CoChat

Topiramate Treatment for Women With Borderline Personality Disorder: A Double-blind, Placebo-Controlled Study

Loew, Thomas H., Nickel, Marius K., Muehlbacher, Moritz, Kaplan, Patrick, Nickel, Cerstin, Kettler, Christian, Fartacek, Rainhold, Lahmann, Claas, Buschmann, Wiebke, Tritt, Karin, Bachler, Egon, Mitterlehner, Ferdinand, Pedrosa Gil, Francisco, Leiberich, Peter, Rother, Wolfhardt K., Egger, Christoph · 2006 · Journal of Clinical Psychopharmacology
Cited by 129

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Borderline personality disorder is a common and severe psychiatric illness. The goal of this study was to determine whether topiramate can influence patients' borderline psychopathology, health-related quality of life, and interpersonal problems. Women meeting the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Structured Clinical Interview II criteria for borderline personality disorder were randomly assigned in a 1:1 ratio to topiramate titrated from 25 to 200 mg/d (n = 28) or placebo (n = 28) for 10 weeks. Primary outcome measures were changes on the Symptom-Checklist, on the SF-36 Health Survey, and on the Inventory of Interpersonal Problems. Body weight and additional side effects were assessed weekly. According to the intent-to-treat principle, significant changes (all P < 0.001) on the somatization, interpersonal sensitivity, anxiety, hostility, phobic anxiety, and Global Severity Index scales of the Symptom Checklist were observed in the topiramate-treated subjects after 10 weeks (no significant changes on the obsessive-compulsive, depression, paranoid ideation, and psychoticism scales). In the SF-36 Health Survey, significant differences were observed on all 8 scales (all P < 0.01 or P < 0.001). In the Inventory of Interpersonal Problems, significant differences (all P < 0.001) were found in the scales for overly autocratic, overly competitive, overly introverted, and overly expressive (no significant differences in the scales for overly cold, overly subassertive/subservient, overly exploitable/compliant, and overly nurturant/friendly). Weight loss was additionally observed (p < 0.001). Topiramate appears to be a safe and effective agent in the treatment in women with borderline personality disorder. Additional weight loss can be expected.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.jcp.0000195113.61291.48

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 129

Metadata

Authors
Loew, T. H., Nickel, M. K., Muehlbacher, M., Kaplan, P., Nickel, C., Kettler, C., Fartacek, R., Lahmann, C., Buschmann, W., Tritt, K., Bachler, E., Mitterlehner, F., Pedrosa Gil, F., Leiberich, P., Rother, W. K., & Egger, C.
Venue
Journal of Clinical Psychopharmacology
Published
2006-02
Volume
26
Issue
1
Pages
61-66
ISSN
0271-0749 (ISSN-L)
OpenAlex
W2003885683
Cited by
129
References
7
FWCI
16.44
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Topiramate Treatment for Women With Borderline Personality Disorder: A Double-blind, Placebo-Controlled Study. https://app.cochat.ai/papers/10.1097/01.jcp.0000195113.61291.48
The paper
Loew, T. H., Nickel, M. K., Muehlbacher, M., Kaplan, P., Nickel, C., Kettler, C., Fartacek, R., Lahmann, C., Buschmann, W., Tritt, K., Bachler, E., Mitterlehner, F., Pedrosa Gil, F., Leiberich, P., Rother, W. K., & Egger, C. (2006). Topiramate Treatment for Women With Borderline Personality Disorder: A Double-blind, Placebo-Controlled Study. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/01.jcp.0000195113.61291.48

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.